Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman
February 15 2024 - 7:30AM
Evome Medical Technologies Inc. (the “
Company” or
“
Evome”) announces the appointment of two senior
healthcare executives to its Board of Directors.
Mr. Wayne Anderson, former President and CEO of
Ferring Pharmaceuticals USA, has joined as a non-executive member
of the Board of Directors.
Mr. Bill Garbarini, a former Ferring
Pharmaceuticals USA executive and current COO of Conceivable Life
Sciences, a venture backed in-vitro fertilization company, will
also join as a non-executive member of the Board of Directors.
In addition, Kenneth Kashkin, MD, has been
appointed Chairman of the Board of Directors. Dr. Kashkin is Board
Certified in Internal Medicine, Neurology & Psychiatry with
training at, and serving on, the faculties of the
University of California, Los Angeles (UCLA) and Yale University
Schools of Medicine. He has led development at divisions of Bayer,
Abbott, Knoll/BASF Pharma and Baxter.
“Now that we have successfully executed on our
turnaround plan, I am pleased to have Wayne and Bill join the
Board," said Mike Seckler, CEO of Evome. “I worked with both of
these talented and successful healthcare executives for many years
while at Ferring and I am eager to benefit from their valuable
guidance and expertise, particularly in the realms of product
launch and commercialization. Dr. Kashkin's contributions will play
a crucial role in advancing our innovation and development
strategies, aligning with our vision to democratize our Biodex
Brands. I can now say we have completed all of the necessary steps
to transform our company. We have driven revenue growth, developed
new products, cut costs and restructured our debt. The final step
was to add some seasoned talent to our Board to assist us in
driving shareholder value.”
For more information please contact:
Mike SecklerChief Executive OfficerTel: 1 (800)
760-6826Email: info@evomemedical.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Evome Medical Technologies (TSXV:EVMT)
Historical Stock Chart
From Dec 2024 to Jan 2025
Evome Medical Technologies (TSXV:EVMT)
Historical Stock Chart
From Jan 2024 to Jan 2025
